B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The long-range goal of this proposal is to decrease morbidity and mortality related to
pulmonary edema and congestive heart failure (CHF) in post-operative patients. The
short-range goal is to determine a mechanistic endpoint when therapy for impending heart
failure can be initiated and terminated based on B-type natriuretic peptide (BNP) levels. The
investigators propose to utilize changing levels of BNP as a surrogate marker for CHF.